Angelina Jolie wrote an op-ed two years ago in The New York Times, taking millions of readers on an intimate journey behind her decision to have a preventive double mastectomy. On Tuesday, the actress boldly acknowledged in the Times that she has had surgery to remove her ovaries and fallopian tubes to minimize her cancer risk. Reactions to her article were swift and generally positive from many in the medical community, as well as from women who, like the actress, have a BRCA gene mutation. Ursula Matulonis, associate professor of medicine at Dana-Farber Cancer Institute, and Christopher Crum, professor of pathology at Brigham and Women’s Hospital, are quoted.
Trending News
Research Provides Clues to Spleen’s Role in Coronary Artery Disease
Genetic variants may drive visible changes in the spleen that contribute to heart disease
Patient Who Received Pig Kidney Becomes First To Progress to Human Kidney Transplant
Study shows xenotransplantation can serve as a bridge for patients with end-stage kidney disease
Pilots, Flight Attendants Have Greater Risk of Radiation-Related Cancer Death Than Other Professions
Findings support efforts to protect U.S. aircrews from cosmic radiation exposure